Literature DB >> 12498376

Effects of Clarion electrode design on mapping levels in children.

Kevin H Franck1, Udayan K Shah, Roger R Marsh, William P Potsic.   

Abstract

The design of the placement of the Clarion cochlear implant's intracochlear electrode array has undergone 2 revisions since its introduction, each to improve modiolar proximity. Stimulation with modiolar proximity may reduce current requirements for threshold levels and most comfortable levels of stimulation. This study analyzed the effects of electrode design on programming levels for deaf children implanted with the 3 cochlear implant designs and followed at The Children's Hospital of Philadelphia. Psychophysical data were reported if measurements were taken approximately 3 months after initial activation, and programming parameters included nonsequential monopolar stimulation of 75-micros-per-phase biphasic pulses presented at 813 Hz per electrode. The threshold level and most comfortable programming level were measured by standard clinical techniques appropriate for children. The results indicate that the 2 electrode placement revisions have each significantly reduced threshold levels and most comfortable stimulation levels. These results are discussed in the context of device aesthetics, safety, and function.

Entities:  

Mesh:

Year:  2002        PMID: 12498376     DOI: 10.1177/000348940211101212

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  2 in total

1.  Frequency and electrode discrimination in children with cochlear implants.

Authors:  Jonathan C Kopelovich; Marc D Eisen; Kevin H Franck
Journal:  Hear Res       Date:  2010-05-27       Impact factor: 3.208

2.  Programming characteristics of cochlear implants in children: effects of aetiology and age at implantation.

Authors:  Paola V Incerti; Teresa Y C Ching; Sanna Hou; Patricia Van Buynder; Christopher Flynn; Robert Cowan
Journal:  Int J Audiol       Date:  2017-09-08       Impact factor: 2.117

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.